Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting

The cytochrome P450 2C9 and vitamin K epoxide reductase complex subunit 1 genotypes are associated with anticoagulation control and the clinical events in warfarin therapy. However, the clinical utility of gene-based warfarin dosing (GBWD) is controversial. We compared the anticoagulation control an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinhua, Wu, Tingting, Chen, Wenjun, Fu, Jinglan, Xia, Xiaotong, Chen, Liangwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988825/
https://www.ncbi.nlm.nih.gov/pubmed/32038232
http://dx.doi.org/10.3389/fphar.2019.01527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988825/
https://www.ncbi.nlm.nih.gov/pubmed/32038232
http://dx.doi.org/10.3389/fphar.2019.01527

Ejemplares similares